Clinician Perspectives on Monoclonal Antibody Treatment for High-Risk Outpatients with COVID-19: Implications for Implementation and Equitable Access.

ABSTRACT:

Background

There is an urgent need to identify and address factors influencing uptake and equitable access to monoclonal antibody (mAb) treatment for high-risk outpatients with COVID-19.

Objective

To assess clinician knowledge, beliefs, and experiences regarding obtaining mAb treatment for eligible patients.

Design and participants

Survey of clinicians (N = 374) practicing in the state of Colorado who care for patients with COVID-19 in primary care, emergency medicine, and other clinical settings.

Main measure(s)

Diffusion of innovation theory concepts including knowledge, perceived strength of evidence, barriers, and experience with, ease of use, preparedness, and feasibility, appropriateness, and acceptability of mAb referral systems and processes.

Key res

SUBMITTER: Kwan BM 

PROVIDER: S-EPMC9255528 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature